Research
Hormonal
Tirzepatide, a dual GLP-1/GIP receptor agonist, demonstrates superior kidney and cardiovascular benefits compared to GLP-1 RAs alone, including significant reductions in albuminuria and eGFR decline.
Tirzepatide (Mounjaro/Zepbound) is a newer option that targets both GLP-1 and GIP hormones. It may offer better kidney and heart protection than older GLP-1 drugs. Discuss with your doctor if you have kidney disease, as it can slow kidney function decline significantly. It is also highly effective for weight loss.
GoodSupportsHIGH confidence
Evidence continues to build that supports benefits to the heart and kidneys of the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist tirzepatide... tirzepatide use was associated with a slower rate of eGFR decline, lower albuminuria, and significantly reduced occurrence of the composite kidney endpoint
Why this rating
Based on post-hoc analyses and pooled data; dedicated kidney outcome trials (FLOW, SOUL) are ongoing.
Source
Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease
Radica Z. Alicic et al. · Journal of Clinical Medicine · 2023
DOI 10.3390/jcm13010201
narrative_reviewCited 10×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →